Search Results - "Chialà, C"

Liver stiffness based model predicts portal hypertension, esofageal varices and hepatocellular carcinoma in caucasian patients with hepatitis B virus-related cirrhosis responsive to antiviral therapy by Chialà, C, Venon, W.D, Tucci, A, Fadda, M, Saracco, G.M, Marzano, A

Get full text

Liver Stiffness Based Model (LSPS) predicts portal hypertension (PH), esofageal varices (EV) and HCC in Caucasian patients with HBV-related cirrhisis responsive to antiviral therapy by Tucci, A, Debernardi Venon, W, Chialà, C, Fadda, M, Saracco, G.M, Marzano, A

Get full text

P0903 : Slow HCV kinetics following sofosbuvir + ribavirin administration in real-life setting of liver transplant recipients with severe recurrent hepatitis C by Cento, V, Donato, M.F, Lenci, I, Rendina, M, Milana, M, Di Maio, V.C, Monico, S, Aragri, M, Alfieri, R, Abedrabbo, A, Sforza, D, Manuelli, M, Mameli, L, Sorbo, M.C, Canu, R, Ponti, M.L, Chialà, C, Malinverno, F, Marenco, S, Milanesi, L, Picciotto, A, Rossi, G, Di Leo, A, Tisone, G, Zamboni, F, Ganga, R, Colombo, M, Perno, C.F, Angelico, M, Ceccherini-Silberstein, F

Get full text

OC.08.9: GEOGRAPHIC DIFFERENCES IN PATIENTS WITH BARRETT'S ESOPHAGUS: PRELIMINAR RESULTS OF THE IOBER PROJECT by Iascone, V., Dajti, E., Wy Chiu, P., Eusebi, L.H., Colecchia, L., Panarese, A., Conigliaro, R.L., Pukitis, A., Chialà, C., Pallio, S., Hs Lau, L., Kl Chan, F., Bazzoli, F., Zagari, R.M.

Get full text

P789 EARLY VIROLOGICAL RESPONSE IS THE MAIN PREDICTOR OF VIRAL ERADICATION IN HCV HAEMODIALYSIS PATIENTS TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN by Rendina, M, Tucci, A, Castellaneta, A, Castellaneta, N.M, Zappimbulso, M, Chiala', C, Leandro, G, di Leo, A

Get full text

Liver stiffness-spleen size-to-platelet ratio risk score (LSPS) detects esophageal varices and HCC risk in HCV- and HBV-related cirrhosis responsive to DAA by Imperatrice, B., Venon, W. Debernardi, Chialà, C., Saracco, G.M., Marzano, A.

Get full text

Outcome of liver grafts procured from hepatitis C-positive donors in the era of direct-acting antiviral drugs: a preliminary single centre experience by Martini, S., Calvo, F., Chialà, C., Tandoi, F., Mirabella, S., Ottobrelli, A., Amoroso, A., Salizzoni, M., Saracco, G.M., Romagnoli, R.

Get full text

FRI-021 - Outcome of liver grafts procured from hepatitis C-positive donors in the era of direct-acting antiviral drugs: a preliminary single centre experience by Martini, S., Calvo, F., Chialà, C., Tandoi, F., Mirabella, S., Ottobrelli, A., Amoroso, A., Salizzoni, M., Saracco, G.M., Romagnoli, R.

Get full text

THU-480 - Liver stiffness based model predicts portal hypertension, esofageal varices and hepatocellular carcinoma in caucasian patients with hepatitis B virus-related cirrhosis responsive to antiviral therapy by Chialà, C., Venon, W.D., Tucci, A., Fadda, M., Saracco, G.M., Marzano, A.

Get full text

OC.04.6 EARLY VIROLOGICAL RESPONSE IS THE MAIN PREDICTOR OF VIRAL ERADICATION IN HCV HAEMODIALYSIS PATIENTS TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN by Rendina, M, Tucci, A, Castellaneta, A, Castellaneta, N.M, Chiala', C, Leandro, G, Gesualdo, L, Di Leo, A

Get full text

Early virological response is the main predictors of viral eradication in HCV haemodialysis patients treated with pegylated interferon plus ribavirin by Tucci, A, Rendina, M, Castellaneta, A, Castellaneta, N.M, Zappimbulso, M, Leandro, G, Chiala’, C, Gesualdo, L, Di Leo, A

Get full text

Impact of mTOR inhibition on expression of immune regulatory molecules by circulating dendritic cells and regulatory T cells in stable liver transplant patients by Castellaneta, A, Massaro, A, Rendina, M, Castellaneta, N.M, D’Errico, F, Chiala’, C, Tucci, A, Thomson, A.W, Di Leo, A

Get full text

FRI-022 - Preemptive direct-acting antiviral therapy in naive or NS5A-relapser liver transplant recipients: a single centre experience by Martini, S., Chialà, C., Calvo, F., Tandoi, F., Patrono, D., Cocchis, D., Ottobrelli, A., Salizzoni, M., Maria Saracco, G., Romagnoli, R.

Get full text

Preemptive direct-acting antiviral therapy in naive or NS5A-relapser liver transplant recipients: a single centre experience by Martini, S., Chialà, C., Calvo, F., Tandoi, F., Patrono, D., Cocchis, D., Ottobrelli, A., Salizzoni, M., Maria Saracco, G., Romagnoli, R.

Get full text

Liver stiffness based model (LSPS) predicts measured portal hypertension (mPH), esophageal varices (EVs) and HCC in patients treated and responsive to DAA for HBV and HCV-related cirrhosis by Tucci, A., Debernardi Venon, W., Pelizza, M., Chialà, C., Ciancio, A., Smedile, A., Saracco, G., Marzano, A.

Get full text

Direct-acting antiviral therapy immediately after liver transplant in naïve or NS5A-relapser recipients by Martini, S., Chialà, C., Calvo, F., Tandoi, F., Patrono, D., Cocchis, D., Ottobrelli, A., Salizzoni, M., Saracco, G.M., Romagnoli, R.

Get full text

Pre-liver transplant cardiovascular risk profile and correlation with early post-transplant cardiac events by Martini, S., Risso, A., Mosso, E., Calvo, F., Chialà, C., Tandoi, F., Marra, W. Grosso, Panio, A., Ottobrelli, A., Saracco, G.M., Romagnoli, R., Lavezzo, B.

Get full text

Immuno-modulating effects of Silibinin in liver transplant patients with HCV recurrence by Castellaneta, A, Massaro, A, Rendina, M, Castellaneta, N.M, D’Errico, F, Tucci, A, Chiala’, C, Brambilla, N, Giacovelli, G, Rovati, L, D’Amato, M, Di Leo, A

Get full text